mozenavir mozenavir mozenavir (dmp-450) is an antiviral drug which was developed as a treatment for hiv/aids. it acts as an hiv protease inhibitor and binds to this target with high affinity, however despite promising results in early testing, mozenavir was unsuccessful in human clinical trials. studies continue into related derivatives. mozenavirclinical datatrade namesmozenavirlegal statuslegal status us: investigational new drug identifiers iupac name (4r,5s,6s,7r)-1,3-bis-4,7-dibenzyl-5,6-dihydroxy-1,3-diazepan-2-one cas number174391-92-5pubchem cid154044chemspider135759unii64oo8946ercomptox dashboard (epa)dtxsid40169822 chemical and physical dataformulac33h36n4o3molar mass536.7 g·mol−13d model (jsmol)interactive image smiles c1=cc=c(c=c1)c2(((n(c(=o)n2cc3=cc(=cc=c3)n)cc4=cc(=cc=c4)n)cc5=cc=cc=c5)o)o inchi inchi=1s/c33h36n4o3/c34-27-15-7-13-25(17-27)21-36-29(19-23-9-3-1-4-10-23)31(38)32(39)30(20-24-11-5-2-6-12-24)37(33(36)40)22-26-14-8-16-28(35)18-26/h1-18,29-32,38-39h,19-22,34-35h2/t29-,30-,31+,32+/m1/s1key:kyrsnwpssxsnep-zrthhsrssa-n